Tradestie Institutional Equity Comparison Engine

AAPG vs IONS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IONS Overall Edge

IONS Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ionis Pharmaceuticals, Inc. Common Stock (IONS) driven by superior Growth & Margin, Momentum & Technical while AAPG counters with relative strength in Valuation, Options & Structure. Fundamentally, AAPG trades at 9.7x Forward P/E with -219.5% operating margin (+29.3% YoY revenue) versus IONS at 90.9x Forward P/E and -58.8% operating margin (+54.9% YoY). In options structure, AAPG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AAPG
AAPG 9.7x vs IONS 90.9x Fwd P/E
Growth & Margin Winner IONS
Op Margin -219.5% vs -58.8% ยท YoY +29.3% vs +54.9%
Momentum & Technical Winner IONS
1Y -59.8% vs -59.1% ยท 52W Pos 0% vs 2%
Options & Structure Winner AAPG
UNCLASSIFIED (N/A IV) vs BREAKDOWN (17th %ile IV)
AAPG NASDAQ
Ascentage Pharma Group International American Depository Shares
Pharmaceutical Preparations
$13.43
-8.14% 1D
Market Cap $1.4B
1M Return -12.62%
1Y Return -59.79%
Forward P/E 9.7x
Unified AI Score
50.2 / 100 HOLD
Tech 58.0 Fund 60.0 Flow 50.0 Mom 60.0
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AAPG -59.79% IONS -59.1% Spread: +1.02 pp (IONS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AAPG TTM Op. Margin: -219.5% IONS TTM Op. Margin: -58.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAPG vs IONS. Trailing 12-month operating profitability (AAPG -219.5% vs IONS -58.8%) and valuation multiples (AAPG 9.7x vs IONS 90.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AAPG (3) vs IONS (7)
Institutional Metric AAPG IONS Criterion Row Winner
Market Capitalization Scale $1.4B $4.7B Larger Scale IONS
Trailing P/E Ratio Valuation 9.7x 90.9x Lower Multiple AAPG
Forward P/E Ratio Valuation 9.7x 90.9x Lower Multiple AAPG
Revenue Growth (YoY) Growth +29.3% +54.9% Higher Growth IONS
Operating Margin (TTM) Profitability -219.5% -58.8% Higher Margin IONS
Net Profit Margin Profitability -228.5% -56.9% Higher Margin IONS
Return on Equity (ROE) Capital Efficiency -236.6% -108.0% Higher ROE IONS
52-Week Range Position Momentum 0% ($13โ€“$34) 2% ($27โ€“$87) Stronger Trend IONS
Beta / 30D Volatility Risk Regime 1.31ฮฒ ยท 69% Vol 0.18ฮฒ ยท 86% Vol Lower Realized Risk AAPG
Unified Institutional Score Composite Signal 50.2 / 100 (HOLD) 63.9 / 100 (BUY) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AAPG vs IONS Buy Guide
AAPG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAPG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AAPG nor IONS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.